Germany and Serbia weaken Stada's six-month performance

Stada's domestic sales fell by 8% to €260 million in the first six months of this year, while those in Serbia, the company's seventh largest individual market, fell by 21% to €36 million. The decline was partially offset by the 24% growth of sales to €97 million in Russia, its second most important national market.

Stada's domestic sales fell by 8% to €260 million in the first six months of this year, while those in Serbia, the company's seventh largest individual market, fell by 21% to €36 million. The decline was partially offset by the 24% growth of sales to €97 million in Russia, its second most important national market.

The German firm's total sales rose by 3% to €778 million, with its international sales growing by 9% to €518...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip